HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hiroaki Ueno Selected Research
Hiroaki Ueno Research Topics
Disease
8
Type 2 Diabetes Mellitus (MODY)
11/2021 - 09/2007
6
Obesity
11/2022 - 12/2007
6
Body Weight (Weight, Body)
02/2018 - 03/2005
5
Infections
10/2006 - 01/2005
4
Inflammation (Inflammations)
11/2016 - 08/2005
3
Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2015 - 10/2011
3
Hypoglycemia (Reactive Hypoglycemia)
01/2015 - 11/2004
3
Insulin Resistance
01/2012 - 10/2010
3
Atrophy
08/2011 - 01/2005
3
Anorexia Nervosa
07/2010 - 11/2003
2
Diabetes Mellitus
12/2022 - 11/2022
2
Dyslipidemias (Dyslipidemia)
11/2022 - 12/2015
2
Peripheral Nervous System Diseases (PNS Diseases)
01/2018 - 01/2017
2
Hypertension (High Blood Pressure)
12/2015 - 10/2011
2
Hyperglycemia
06/2015 - 12/2007
2
Neoplasms (Cancer)
06/2014 - 07/2010
2
Liver Diseases (Liver Disease)
01/2012 - 11/2004
2
Vomiting
08/2006 - 11/2004
2
Bulimia Nervosa
08/2006 - 01/2005
2
Gastritis
01/2005 - 09/2004
1
Wounds and Injuries (Trauma)
01/2018
1
Hypersensitivity (Allergy)
01/2018
1
Hypercholesterolemia
01/2012
1
Fatty Liver
01/2012
1
Arteriosclerosis
10/2011
1
Muscular Atrophy (Muscle Atrophy)
08/2011
1
Heart Failure
07/2010
1
Cachexia
07/2010
1
Dyspepsia (Indigestion)
07/2010
1
Diabetes Complications
12/2007
1
Diabetic Nephropathies (Diabetic Nephropathy)
12/2007
1
Atherosclerosis
12/2007
1
Body Weight Changes
10/2006
1
Bulimia (Binge Eating)
08/2006
1
Crohn Disease (Crohn's Disease)
12/2005
1
Weight Loss (Weight Reduction)
12/2005
1
Malnutrition (Nutritional Deficiencies)
12/2005
1
Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
05/2005
1
Atrophic Gastritis
01/2005
1
Starvation
11/2004
1
Emaciation
11/2004
Drug/Important Bio-Agent (IBA)
20
Ghrelin
IBA
01/2018 - 11/2003
8
Glucose (Dextrose)
FDA Link
Generic
02/2018 - 11/2003
7
Peptides (Polypeptides)
IBA
11/2022 - 03/2005
6
Insulin (Novolin)
FDA Link
02/2018 - 11/2003
3
Growth Hormone (Somatotropin)
IBA
07/2010 - 11/2004
3
Hormones (Hormone)
IBA
05/2005 - 01/2005
2
Anti-Obesity Agents (Antiobesity Drugs)
IBA
11/2022 - 12/2015
2
Uric Acid (Urate)
IBA
02/2018 - 10/2011
2
Lipids
IBA
01/2012 - 10/2011
2
Cholesterol
IBA
01/2012 - 10/2011
2
oxidized low density lipoprotein
IBA
01/2012 - 10/2011
2
Triglycerides (Triacylglycerol)
IBA
01/2012 - 10/2011
2
Leptin
IBA
08/2006 - 12/2005
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
12/2022
1
Glucagon (Glukagon)
FDA Link
02/2018
1
ipragliflozin
IBA
02/2018
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2018
1
Antioxidants
IBA
01/2018
1
Ghrelin Receptors
IBA
01/2018
1
NAD (NADH)
IBA
01/2017
1
Acarbose
FDA Link
Generic
06/2015
1
miglitol (Glyset)
FDA Link
06/2015
1
Sitagliptin Phosphate (Januvia)
FDA Link
06/2015
1
Incretins
IBA
06/2015
1
3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidine
IBA
01/2015
1
Blood Glucose (Blood Sugar)
IBA
01/2015
1
Glucagon-Like Peptide 1 (GLP 1)
IBA
07/2014
1
Integrin alpha5beta1
IBA
06/2014
1
Integrin alpha4beta1 (VLA-4)
IBA
06/2014
1
Albumins
IBA
03/2013
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
01/2012
1
Ezetimibe (Zetia)
FDA Link
01/2012
1
HDL Cholesterol
IBA
01/2012
1
C-Reactive Protein
IBA
01/2012
1
lathosterol
IBA
01/2012
1
Fenofibrate (CiL)
FDA Link
Generic
10/2011
1
Serum Amyloid A Protein (Serum Amyloid A)
IBA
10/2011
1
LDL Lipoproteins (beta Lipoproteins)
IBA
10/2011
1
Fibrinogen (Factor I)
FDA Link
10/2011
1
fibrin fragment D (D-dimer)
IBA
10/2011
1
des-n-octanoyl ghrelin
IBA
08/2011
1
Angiotensin Receptor Antagonists
IBA
10/2010
1
Creatinine
IBA
12/2007
1
Pioglitazone (Actos)
FDA Link
09/2007
1
Thiazolidinediones
IBA
09/2007
1
Paroxetine (Paxil)
FDA Link
Generic
08/2006
1
Serotonin (5 Hydroxytryptamine)
IBA
08/2006
1
Messenger RNA (mRNA)
IBA
08/2005
1
Amoxicillin (Wymox)
FDA Link
Generic
08/2005
1
Lansoprazole (Prevacid)
FDA Link
Generic
08/2005
1
Clarithromycin (Biaxin)
FDA Link
Generic
08/2005
1
Pepsinogen A (Pepsinogen)
IBA
01/2005
1
Peptide YY
IBA
01/2005
Therapy/Procedure
6
Therapeutics
12/2015 - 08/2005
3
Glycemic Control
11/2021 - 12/2007
2
Aftercare (After-Treatment)
10/2011 - 08/2006
1
Intranasal Administration
07/2014
1
Duration of Therapy
03/2013
1
Bed Rest (Bedrest)
08/2011